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ABSTRACT
The effects of agents that elevate intracellular cyclic adenosine 3',5'-monophosphate
(cAMP) have been studied with respect to phagocytosis by guinea pig polymorphonuclear
leukocytes. The investigation depends upon the use of a precise method for following in-
gestion. Theophylline, dibutyryl cAMP, and prostaglandins inhibited the phagocytosis of
starch particles. The inhibitions caused by prostaglandins E l , E2 , and F2a (PGEI , PGE2 ,
and PGF2) were synergistic with that due to theophylline . Inhibition by PGA, and PGA2
was not. At equal concentrations the order of increasing inhibition of phagocytosis (as-
sayed at 10 min) by the prostaglandins was PGE, < PGF 20 < PGE2 < PGA, = PGA2 .
Our results are consistent with the hypothesis that increased intracellular levels of cAMP
impair the phagocyte's ability to ingest particles. The mechanism of the inhibition has not
been defined. The increment in oxidation of [1i'C]glucose to '4C02 that normally accom-
panies phagocytosis was found to be depressed in the presence of PGE, or theophylline, to-
gether or individually as expected from the inhibition of phagocytosis . Paradoxically,
oxygen consumption although depressed by theophylline or PGE I plus theophylline, was
stimulated by PGE, alone.
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INTRODUCTION
The ubiquitous role of cyclic adenosine 3',5'-mo-
nophosphate (CAMP)' as a regulatory agent in-
volved in the control of a number of cell processes
is well documented (Robison et al., 1971) . In-
cluded among cAMP-sensitive cellular processes
are a number of exo- and endocytotic phenomena .
Thus, increased intracellular cAMP levels have
'Abbreviations used in this paper are : cAMP-cyclic aden-
osine 3',5'-monophosphate; KRP-Krebs-Ringer
phosphate medium, pH 7.4; PGE,, PGE2, PGA,,
PGA2, PGF2«-prostaglandins El, E2, A,, A2, or
F2a; PMN-polymorphonuclear leukocytes.
been correlated with increased insulin release from
pancreatic islets (Sussman and Vaughan, 1967),
increased ACTH, thyroid-stimulating hormone
(TSH), and growth hormone release from the
anterior pituitary (Fleischer et al., 1969 ; Bowers
et al., 1968; Gagliardino and Martin, 1968) and
release of thyroid hormone and calcitonin by
thyroid cells (Ensor and Munro, 1969 ; Care et al.,
1969) . Phagocytosis of latex beads by thyroid cells
(Kowalski et al., 1972) was also enhanced. These
observations together with recent evidence im-
plicating cAMP in the regulation of several leuko-
cyte functions such as allergic histamine release
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(Stossel et al., 1972; Bourne et al., 1971 ; Weiss-
mann et al., 1971), candidacidal activity (Bourne
et al., 1971), iodide metabolism (Stoic, 1972),
release of lysosomal enzymes (May et al ., 1970)
and lymphocyte transformation (Smith et al.,
1971 a, b) prompted us to examine the effects of
CAMP and the prostaglandins on phagocytosis by
polymorphonuclear leukocytes (PMN) . It has
been established that the PMN contain the enzy-
matic machinery for the synthesis and degradation
of CAMP and that prostaglandins increase the
intracellular accumulation of CAMP in these cells
(Butcher and Baird, 1968 ; Scott, 1970; Bourne
et al., 1971 ; Bourne and Melmon, 1971 ; Stossel
et al., 1970 ; Stoic, 1972 ; Woodin, 1972; Bourne
et al., 1973) .
We have found that agents reported to effect an
increase in intracellular CAMP levels inhibit the
ingestion of starch particles by guinea pig PMN
in a dose-related manner. This was true whether
the increase in intracellular CAMP was brought
about by the exogenous nucleotide in the form of
the dibutyryl derivative, by the phosphodiesterase
inhibitor theophylline, or by activators of adenyl
cyclase such as the prostaglandins. The inhibi-
tion of phagocytosis brought about by PGE1,
PGE2 and PGF2a was potentiated by theophylline,
i.e., was beyond the level expected if each agent
acted independently. Although not conclusive,
this evidence is consistent with the probability that
inhibition of phagocytosis by the prostaglandins
is a result of their stimulation of adenyl cyclase .
MATERIALS AND METHODS
Chemicals
All chemicals used were of reagent grade and were
purchased from commercial sources. CAMP, theo-
phylline (Mann Research Lab. Inc., N. Y.), and
dibutyryl CAMP (Sigma Chemical Co., St. Louis,
Mo.) were dissolved in Krebs-Ringer phosphate
solution, pH 7.4 (KRP), containing 7 .5 mM glucose.
These solutions were freshly prepared for each experi-
ment. Prostaglandins El, E2, A1, A2, and F2 a were
kindly supplied by Dr. J. Pike of the Upjohn Co.,
Kalamazoo, Mich . Stock solutions at 1.0 mg/ml were
prepared by dissolving the free acids in 95.0%
ethanol, 0.002 M sodiun carbonate 1 :9, and adjust-
ing the pH to 6.7. A solution containing similar pro-
portions of carbonate and ethanol and adjusted to pH
6.7 was used as a control .
Preparation of Cellular
Monolayers of Guinea Pig
Polymorphonuclear Leukocytes
Elicited peritoneal exudate PMN were collected
and washed in Krebs-Ringer Phosphate medium as
described in previous publications from this labora-
tory (Oren et al., 1963) . Cell monolayers were pre-
pared by incubation of 1 .0 ml of a cell suspension at a
concentration of 1 .0' X 107 cells/ml in plastic culture
dishes as detailed by Michell et al., 1969).
A very brief summary of the procedure is as follows
Cells were obtained from the peritoneal cavities of
guinea pigs 18 h after the injection of neutral caseinate
solution (12% in physiological saline) . The cells were
centrifuged, washed once in KRP, resuspended in
KRP, and counted in a hemocytometer. After ap-
propriate dilution 1-ml aliquots were pipetted into
small Petri dishes for tissue culture (Falcon Plastics,
Division of B-D Laboratories, Inc., Los Angeles) and
incubated for 1 h. Excess cells were then decanted and
the dishes washed in three successive beakers contain-
ing KRP.
Measurements of Rates of Phagocytosis
Ingestion of radioactively labeled starch particles
by cellular monolayers was employed as a measure
of phagocytic activity as described by Michell et al .
(1969). Approximately 1 .0 X 107 cells were used in
the preparation of each monolayer resulting in the
recovery of 0.4-0.6 mg of cellular protein. After a
30.0 min preincubation with drug-containing or
control solution, the monolayers were exposed for a
specified time to 5.0 mg of starch labeled with 14C.
The period of phagocytosis was 5.0-60.0 min in pre-
liminary time-course experiments, and 10 .0 min in all
other uptake experiments. To terminate phagocyto-
sis, the monolayers were washed free of excess par-
ticles through six beakers of 0 .9% NaCl. The amount
of starch ingested was determined by counting the
residual radioactivity in air-dried monolayers on a
gas flow counter (Michell et al ., 1969). Uptake of
starch particles was expressed as milligrams ingested
starch (based on the specific activity of the labeled
particles) per milligram of cellular protein, deter-
mined by assaying appropriate aliquots of the NaOH-
digested monolayers by the method of Lowry et al .
(1951). The amount of phagocytosis exhibited by
duplicate drug-treated monolayers was expressed as
the percentage of that in duplicate control mono-
layers.
Metabolic Studies
Oxygen consumption was measured by Warburg
respirometry concomitantly with the oxidation of
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481[1-19C]glucose to 14CO2 in 15.0-m1 capacity flasks
containing 3.0 ml of medium and 0.2 ml of KOH in
the center-well as previously described (Sbarra and
Karnovsky, 1959).
RESULTS
Effect of Various Agents that Increase
Intracellular cAMP Levels on the
Time Course of Phagocytosis
Phagocytosis is a saturable process which shows
an initial linear rate and then levels off at maximal
cellular capacity (Michell et al ., 1969 ; Stossel
et al., 1972) . We first screened the agents for their
effects at various times during the uptake process
since it was conceivable that rate of phagocytosis
or capacity of the cells for particles might be selec-
tively affected. In Fig. 1, a representative experi-
ment is depicted on the effects of PGE, (20 .0
µg/ml; 5.6 X 10-1 M), theophylline (5.0 mM),
and dibutyryl cAMP (1 .0 mM and 5 .0 mM) on
the time course of phagocytosis . The insert depicts
the kinetics of uptake for untreated (control)
PMN. It is clear that all of the agents employed
diminished phagocytosis substantially at early
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FIGURE 1 Time course of inhibition of starch uptake by agents that affect intracellular levels of cAMP .
The ordinate refers to uptake of [14C]starch (expressed as % inhibition), and the abscissa represents the
period of exposure of cells to particles . Monolayers were exposed to the drugs at 37°C for 30 min before
particles were added. The points are mean values from a representative experiment done in duplicate .
Deviation from the mean averaged f2.01yo for the theophylline (5 MM) curve (•) ; ±3.2% for the 5.0
mM dibutyryl cAMP curve (X) ; ±3.3% for the 1.0 mM dibutyryl CAMP curve (O), and 5.0% for the
PGE1 (5.6 X 10_5 M) curve (O) . The insert depicts the kinetics of starch uptake for the untreated cells .
The ordinate refers to uptake of [14C]starch (expressed as milligrams of starch per milligram of monolayer
protein) and the abscissa, to time of exposure to 5.0 mg of [14C]starch. The individual values deviated
from the mean by no more than 5.0%.
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times when the rate of uptake was maximal
(Michell et al., 1969). At later times when the
capacity for uptake by control cells had nearly
reached its maximum, the inhibition of phagocy-
tosis tended to be relieved. Although the amount of
inhibition produced by 5.0 mM theophylline and
5 .0 mM dibutyryl cAMP remained significant
even 60.0 min after cells had been presented with
particles, that brought about by PGE, and 1 .0 mM
dibutyryl cAMP had all but disappeared after
15 .0 and 30.0 min respectively. The effects thus
depend upon critical timing and concentrations .
Several other experiments of this type demon-
strated slight shifts in optimal timing, optimal
concentrations of agents, and the degree of
inhibition observed with different batches of cells .
The prostaglandins are compared in Fig . 2.
Once again it can be seen that the inhibitions are
maximal during the period of linear uptake in
control cells (< 15 min) (see Fig. 1) . Not only
PGE,, but also PGE2, PGA,, PGA 2 , and
PGF2. were found to inhibit phagocytosis in
PMN. PGA, and PGA2 were more potent in-
hibitors than PGE1, PGE2, and PGF2. in that
their effects were more sustained at later times .120
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FIGURE 2 Inhibition of phagocytosis by prostaglandins at various times subsequent to the addition of
[14C]starch. The ordinate refers to uptake of [14C]starch particles, expressed as % control. On the abscissa
is indicated the period of exposure of the monolayers to 5 .0 mg of starch particles . The cells were pre-
incubated for 30.0 min at 37°C in the presence or absence of drugs before the addition of [14C]starch.
The bars represent the average deviation of triplicate samples in a single experiment. All prostaglandins
were applied at a concentration of 20.0 pg/ml = 5.6 X 10-5 M. PGE1 (solid bar) ; PGE2 (slashed hatch-
ing) ; PGF2 (horizontal hatching) ; PGA1 (open bar) ; PGA2 (vertical hatching) .
PGE1 appeared to exhibit a stimulation of phago-
cytic capacity at later times .
Comparison of Agents that Increase
Intracellular cAMP Levels as
Inhibitors of the Rate of Phagocytosis
The inhibitory effect of various agents at differ-
ent concentrations was compared for the most
sensitive part of the normal ingestion curve, i.e.,
when maximal ingestion rates pertained . The
experiments are summarized in Table I . All of the
agents examined were inhibitory when an ap-
propriate concentration was selected . Dibutyryl
sAMP was a more potent inhibitor of phagocytosis
than CAMP itself. It is generally assumed that the
higher efficiency of dibutyryl sAMP in many
cAMP-responsive systems is due to better permea-
tion into cells of the less polar dibutyryl derivative,
or to its higher resistance to phosphodiesterase
(Robison et al., 1971) . However, some doubt has
been cast on this explanation by Szabo and Burke
(1972) who concluded that the effects of dibutyryl
sAMP on thyroid cells were predominantly due to
the substituted nucleotide itself or to N6-mono-
butyryl sAMP rather than to sAMP formed by
deacylation.
15 60
Demonstration of Synergism by
Theophylline and PGE1 or PGE2 in
Depressing Phagocytosis
All of the prostaglandins we examined were able
to inhibit phagocytosis with variations merely in
degree, yet only PGE1 and PGE2 have been shown
so far to be effective activators of leukocyte adenyl
cyclase (Bourne et al., 1971 ; Scott, 1970) . The
question thus arose as to whether or not the
prostaglandin-induced inhibition of phagocytosis
depended upon changes in intracellular sAMP
levels, or whether there were some other effects
peculiar to the chemical nature of prostaglandins.
If the prostaglandins were indeed inhibiting
phagocytosis by virtue of their ability to activate
adenyl cyclase, then it should be possible to
potentiate the inhibition with a phosphodiesterase
inhibitor such as theophylline. The possibility that
theophylline might potentiate the effects of the
prostaglandins was examined using a combination
of the two drugs at concentrations that individually
produced small effects. For theophylline, partic-
ularly, concentrations were below 5 mM, which
it may be noted in Fig. 1 caused a high degree of
inhibition.
In Table II the inhibitory activity of theo-
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483TABLE I
Inhibition of Phagocytosis of Starch Particles by Guinea Pig PMN Monolayers Due to
Agents that Increase Intracellular cAMP Concentrations*
* The monolayers were preincubated at 37 °C for 30.0 min in the presence of drug or
control solutions before the addition of 5 .0 mg of radioactively labeled starch . Phag-
ocytosis was allowed to proceed for 10 .0 min. The data are presented as percentage in-
hibition f SE. The number in parenthesis refers to the number of paired experiments
performed. Each experiment was done in duplicate . For the prostaglandins 1 µg/ml
corresponded to 2.82 µM, 20 µg/ml to 56 .0 µM. P is the probability value for the
significance of the inhibitions.
phylline and prostaglandins combined is compared
with the inhibition predicted if each agent in-
hibited at a site independent of the other . The data
are segregated into three groups : one in which the
inhibition predicted for independent sites was
between 0 and 50%, averaging at approximately
35%, a second in which predicted inhibitions fell
between 50 and 757, averaging at about 65%,
and a third in which predicted inhibitions were
above 75%, averaging near 807. The range of
drug concentrations used to obtain predicted levels
of inhibition <75 %were as follows: theophylline,
1 .0-3.0 mM; PGE1, 10.0-20.0 µg/ml (2.8-5.6 X
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10-5 M) ; PGA,, PGE 2 , and PGA2, 1 .0-10.0
µg/ml; PGF2., 10.0-50.0 µg/ml . For predicted
inhibitions > 75 %the following concentrations of
drugs were required: theophylline, 2 .5-4.0 mM;
PGE1 , 20.0 µg/ml; PGE2, PGA,, and PGA2,
10.0-20.0 µg/ml; PGF2. 20.0-50.0 µg/ml. A
range of theophylline and prostaglandin concen-
trations was utilized in each experiment in order to
obtain inhibitions by the separate agents such that
synergism could be observed in combination . This
strategy was adopted because of variations in
response to separate agents that were manifested
by different batches of cells. When the predicted
Agent Concentration % inhibition P
cAMP
Dibutyryl cAMP
Theophylline
MM
10 .0
2 .0
25.0
1 .25
2 .5
4.0
10 .0
13 .3 t 3 .9
47 .3 f 2 .8
87 .4 f 1 .0
8 .6 t 5 .6
29.0 f 3 .9
48.7 f 3 .1
80.7 f 1 .2
(17)
(6)
(2)
(4)
(11)
(6)
(3)
<0.005
<0 .001
-
<0 .3
<0 .001
<0 .001
<0 .001
PGE1
µM
56.3 19.7 f 10 .2 (6) <0 .10
PGE2 2 .82 17 .3 t 12 .1 (8) <0 .2
28.2 34.4 t 7 .9 (9) <0 .005
56 .3 47 .1 f 5 .6 (4) <0 .005
PGA1 14.1 34.5 f 8 .6 (3) <0 .05
56 .3 57 .3 t 6 .3 (5) <0 .001
PGA2 2 .82 35 .7 f 11 .4 (8) <0 .02
28.2 35 .2 t 6 .3 (9) <0 .001
56 .3 56 .1 f 7 .6 (5) <0 .005
PGF2. 21 .0 9 .8 t 5 .6 (8) <0 .1
42 .0 32 .5 f 10 .4 (11) <0 .01
105.0 33 .6 t 10 .0 (5) <0 .025* The amount of inhibition of phagocytosis obtained when prostaglandin and theophylline were applied
together during a 30-min preincubation period is compared with the amount of inhibition predicted from
that observed when the monolayers were preincubated with each agent alone . Data are entered as percent
plus or minus SE . Numbers in parentheses indicate number of experiments . The significance of the differ-
ences between the experimental values obtained and the predicted values was determined by application
of the Student t test and is entered as P.
$ Predicted inhibition was calculated as follows : Predicted inhibition = inhibition by prostaglandin
(PG) + (100 - inhibition by PG) (inhibition by theophylline/100).
§ Potentiation was calculated in paired experiments as follows : Potentiation = 100 (Inhibition observed/
Inhibition calculated)
inhibition was within the range of 0-50%, it
could be seen that the inhibition of phagocytosis
brought about by PGE1, PGE2 , and PGF2a was
clearly potentiated by theophylline in a significant
fashion. When predicted inhibitions were between
50% and 75%, no potentiation was demonstrable
and the drugs behaved as though they were acting
at independent sites. At levels of inhibition pre-
dicted to be > 75 %, combinations of drugs led to
inhibitions of phagocytosis that were slightly below
the predicted levels. The inhibition by PGAI and
PGA 2 was not potentiated by theophylline even at
concentrations where the predicted amount of
inhibition was within the range where it has been
possible to demonstrate synergism in the case of
PGE I , PGE2, and PGF2. .
TABLE II
Potentiation by Theophylline of the Inhibitory Effect on Phagocytosis Produced by Prostaglandin*
Effects of PGE1 and Theophylline
on Metabolism
Since the increment in oxygen consumption and
glucose oxidation associated with phagocytosis
varies directly with the rate of phagocytosis over a
broad range (Sbarra and Karnovsky, 1959;
Michell et al., 1969; Stossel et al., 1972), it was
expected that the prostaglandins and theophylline
would inhibit these metabolic functions secondarily
to their inhibition of the uptake process itself. This
turned out to be the case for the most part. How-
ever, we were surprised to find that rather than
inhibiting respiration during phagocytosis, PGE1
stimulated it. From Fig. 3 a it can be seen that
neither PGE1 nor theophylline had much effect on
"resting" respiration but preparations containing
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Range of predicted
inhibition Inhibition predicted $ Inhibition observed Potentiation§ P
0-50%
PGE1 36 .5 f 4 .2 (4) 71 .4 t 8.7 (4) 196.4 f 10.3 (4) <0 .005
PGE2 37 .8 f 1 .6 (5) 54 .9 t 6 .2 (5) 148.5 t 22 .0 (5) <0 .025
PGAI 32 .0 t 6.5 (6) 33 .8 f 6.2 (6) 115.0 t 17 .1 (6) NS
PGA2 37 .1 t 8 .6 (4) 37 .1 f 11 .2 (4) 91 .1 f 18 .1 (4) NS
PGF2a 34.2 f 4.1 (8) 46 .1 f 4 .7 (8) 143 .6 f 15 .7 (8) <0 .05
50-75%
PGEI - - - -
PGE2 64 .9 f 2 .4 (8) 66 .8 f 3 .3 (8) 103 .6 f 5.6 (8) NS
PGAI 65 .3 f 3 .6 (6) 65 .3 f 8 .0 (6) 97,1 f 13 .4 (6) NS
PGA2 65 .3 f 1 .5 (10) 65 .1 t 5 .0 (10) 98 .9 f 5 .9 (10) NS
PGF2a 63 .7 f 2 .0 (12) 62 .2 f 2 .1 (12) 97.1 f 6.2 (12) NS
75-100%
PGE1 76 .6 f 1 .1 (2) 72 .6 f 9 .7 (2) 94 .6 f 11 .3 (2) NS
PGE2 78.9 ± 5.3 (3) 66 .8 f 8.4 (3) 84.3 f 8 .5 (3) NS
PGAI 82.1 f 2 .2 (2) 82 .7 f 3 .4 (2) 101 .0 f 6 .8 (2) NS
PGA2 84.0 f 2 .1 (4) 65 .5 f 8.9 (4) 77 .7 t 10 .1 (4) <0 .1
PGF2a 82.5 (1) 65.2 (1) 79 .0 f (1)100
80
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drug diverged from the control with respect to
respiration during ingestion. This is more dramat-
ically brought out in Fig. 3 b where the difference
between phagocytic and resting respiration is
plotted as a function of time . Theophylline alone
clearly eliminates the respiratory burst that
normally accompanies phagocytosis, as might be
expected (see above) whereas PGE1 alone stimu-
lates it even though phagocytosis per se is possibly
slightly depressed (see Table I and Fig . 2) . These
effects were not additive when the two drugs were
applied together, in which instance the inhibitory
effect of theophylline predominated . The increase
in oxygen consumption during phagocytosis is
thought to be due to the activation of a cyanide-
insensitive NADH-oxidase which is present in
these cells (Cagan and Karnovsky, 1964) . Direct
assay of this enzyme in the presence of PGE 1
showed no stimulation (data not shown) . The
increase in oxygen consumption of phagocytizing
PGE1-treated cells relative to phagocytizing con-
trols is abolished in the presence of cyanide,
further eliminating cyanide-insensitive oxidases
as the locus of PGE1 stimulation of respiration.
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FIGURE 3 Effects of PGE1 + theophylline on oxygen consumption in resting and phagocytizing guinea
pig PMN. The ordinate represents the amount of oxygen consumed in Fig . 3 a and the difference in oxygen
consumption between phagocytizing and resting cells in Fig. 3 b, as µl 02. The abscissa refers to the time
of incubation for both Fig . 3 a and Fig. 3 b. The cells were exposed to drugs for 30 min before recording
of oxygen consumption. Each flask contained 1 .0 X 108 PMN. The points represent the mean of dupli-
cate flasks in a single experiment. The broken line (---) in Fig. 3 a represents resting oxygen consump-
tion by control PGE1-treated, theophylline-treated, or PGE1- + theophylline-treated cells . Resting
oxygen consumption after 30 min with or without drugs deviated from the dotted line by an average of
137. The solid lines in Fig. 3 a represent 02 consumption by phagocytizing cells . Deviation from the
mean after 30 min averaged 7% for the control curve (s), 51 1/o for the PGE1 curve (/), and 6% for the
theophylline curve with or without PGE1 (A). In Fig. 3 b the respiratory burst during phagocytosis is
given for: control cells (0), PGE1-treated cells (N), PGE1 + theophylline-treated cells (0), and the-
ophylline treated cells (A) . Theophylline concentration was 9 .5 mM, PGE1 concentration was 5 .6 X
10_5 M.
The effects of these drugs on the oxidation of
[1-14C]glucose to 14CO2 are shown in Fig. 4. Both
drugs (PGE 1 and theophylline) alone and in
combination inhibited the phagocytic stimulation
of glucose oxidation, probably due to inhibition of
ingestion per se . Inhibition of the resting level of
glucose oxidation was minimal except in the case
of the combination of drugs . All metabolic meas-
urements were made for a period of phagocytosis
of 60 min.
DISCUSSION
It is apparent from the data we have presented
that dibutyryl cAMP, theophylline, and prosta-
glandins-all compounds that would be expected
to elevate intracellular cAMP levels-bring about
an inhibition in phagocytosis of starch particles by
guinea pig PMN . The fact that cAMP itself was
the least potent inhibitor may be due to its slow
permeation into cells or to rapid degradation by
phosphodiesterases at the cell surface . At least two
other reports pertinent to our observations have
appeared in the literature . Stossel et al . (1972)
reported briefly that their new method for assaying
45 60120
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FIGURE 4 Effect of PGE1 and theophylline separately and together on the oxidation of [1-C14]glucose
to 14C02. The ordinate refers to the amount of 14CO2 recovered from [1 14C]glucose during a 60-min incu-
bation (expressed as % of control). The state of the cells (resting or phagocytizing) is indicated ; 0 repre-
sents the difference in 14C02 production between phagocytizing and resting cells . The cells were preincu-
bated with drug for 30 min before the addition of [1 14C]glucose. Bars indicated average deviation be-
tween duplicate experiments each done in triplicate . PGE1 (5.6 X 10'5 M), open bar; theophylline (2.5
mM), slashed hatching; PGE1 (5.6 X 10-5 M) plus theophylline (2.5 mM), horizontal hatching.
rates of phagocytosis by use of albumin-stabilized
paraffin emulsions containing Oil Red 0 was able
to detect a diminution of phagocytosis by theo-
phylline or dibutyryl sAMP. Bourne et al. (1971)
claimed that preincubation of neutrophils for 30
min with 3.0 mM dibutyryl CAMP, 1 .0 X 10-'M
PGE,, or 3.0 mM theophylline produced a
"slight but consistent" inhibitory effect on
ingestion of radioactively labeled yeasts which
they deemed insufficient to account for the reduced
candidacidal activity observed in response to these
same drugs. We note, however, that in those
experiments there were inhibitions of ingestion in
the range of 25-40% . Further, Weissmann et al.
(1971) have demonstrated that sAMP, dibutyryl
CAMP, and theophylline inhibit the uptake of
[1251]BSA by mouse macrophages in culture.
We found that not only PGE1 but also PGE 2 ,
PGA1, PGA2. inhibited phagocytosis . PGE1 and
PGE2 are the only prostaglandins that have been
shown thus far to elevate intracellular levels of
CAMP in leukocytes. PGF1, specifically did not
and PGA1 , PGA2 , and PGF2. have not been
studied in this regard (Scott, 1970). We noted that
the behavior of prostaglandin-theophylline com-
binations on the phagocytic response varied ac-
cording to the amount of inhibition expected if
theophylline and prostaglandins were acting at
unrelated sites, as follows : First, if the amount of
inhibition predicted was less than 50%, the in-
hibitory effects of PGE 1 , PGE 2 , and PGF2.
were potentiated by theophylline . Here the data
are in accord with a synergistic effect brought
about by action of the two drugs on the same
system. In view of the well-documented effects of
theophylline and certain prostaglandins on sAMP
metabolism in a number of different tissue and cell
types including the PMN (Butcher and Baird,
1968; Scott, 1970; Bourne et al., 1971 ; Bourne and
Melmon, 1971 ; Stossel et al., 1970; Stolc, 1972 ;
Bourne et al., 1973), these observations would
tentatively implicate a mechanism of inhibition of
phagocytosis by prostaglandins that involves the
adenyl cyclase system. It should be noted how-
ever that under these same conditions, the in-
hibition of phagocytosis effected by PGA1 and
PGA2 was not potentiated by theophylline. Second,
when the predicted inhibition of phagocytosis was
between 50 and 75%, the observed values were
the same as those predicted. This sort of behavior
is consistent with action of the two drugs on in-
dependent systems. The situation with PGA, and
PGA2 mentioned above might be viewed in this
regard, i .e., PGA1 and PGA2 could inhibit phago-
cytosis by a mechanism distinct from one involving
sAMP. Third, when inhibitions in excess of 75%
were predicted, a response was obtained which was
less than that predicted on the basis of independent
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487sites. It is possible that the concentrations of drugs
required to bring about inhibitions of phagocytosis
in excess of 75% approached a threshold required
for them to act as surface active agents and thus
stimulated phagocytosis to some degree . The
prostaglandins in particular would be suspect in
this regard. Stimulation of endocytosis by surface
active agents has been reported (Cohn and Morse,
1960; Graham et al., 1967) . In a complex system
such as a whole cell, combinations of the mech-
anisms suggested above may well be operative as
well as the phenomenon of competitive interaction,
i.e., the possibility that theophylline might dis-
place prostaglandin from a given site and vice
versa.
We believe that the degree to which dibutyryl
cAMP, theophylline, and the prostaglandins in-
hibited phagocytosis in our hands might well have
been sufficient to account for observations made
by others on decreased candidacidal activity
(Bourne et al., 1971), decreased phagocytic release
of f3-glucuronidase (May et al., 1970), and de-
creased iodide metabolism (Stole, 1972) in response
to these drugs. Likewise the inhibition of metabo-
lism in the presence of particles observed by our-
selves and others (Bourne et al ., 1971 ; May et al.,
1970; Weissmann et al ., 1972) could be secondary
to the inhibition of phagocytosis itself. The para-
doxical stimulation of the phagocytic respiratory
burst elicited by PGE1 remains unaccounted for. It
appears not to involve the cyanide-insensitive
oxidase system present in PMN and thought to be
responsible for the increment in respiration during
phagocytosis. This effect is probably not mediated
via the adenylate cyclase system since theophylline
did not potentiate it, although both drugs were
at concentrations at which potentiation by theo-
phylline of inhibitions of phagocytosis by PGE1
were discerned.
Phagocytosis by leukocytes stands alone as an
example of a bulk transport process that is in-
hibited by cAMP. In other such systems studied,
cAMP either stimulated the process or had no
effect. Not only endocytosis (phagocytosis) but also
exocytosis as reflected by allergic histamine release
is inhibited by cAMP in leukocytes (Lichtenstein
and Margolis, 1968). One could speculate that in
the phagocytic PMN, increased intracellular levels
of cAMP, brought about by particle internalization,
might serve as a signal for the cell to stop phago-
cytizing in order that energy supplies may be
replenished and surface membrane replaced . It is
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as yet uncertain whether or not an alteration of
cAMP concentrations is one of the biochemical
manifestations of the phagocytic response . It was
reported by Park et al . (1971) that the cAMP con-
tent of human peripheral blood leukocytes is in-
creased several fold approximately 5 min after the
initiation of phagocytosis . However, others were
not able to confirm these results (Stole, 1972) . It
has been suggested that the increase in cAMP
observed by Park et al . (1971) could have occurred
in cells other than PMN since the leukocytes used
had not been fractionated (Manganiello et al.,
1971) . It is frequently difficult to correlate changes
in a particular physiological response with changes
in total cellular cAMP concentration because of
complications arising from compartmentalization
and local ionic environment.
The mechanism whereby cAMP might act to
control phagocytosis is an intriguing question . In
other systems and especially in case of the cAMP-
stimulated activation of skeletal muscle phosphoryl-
ase, the cAMP effect is thought to involve the
stimulation of a protein kinase (Walsh et al.,
1970) . Indeed, Greengard et al . (1969) have sug-
gested that all the varied effects of cAMP may
result from the phosphorylation of a protein
secondary to the stimulation of a protein kinase. A
report on the presence of a cAMP-dependent
protein kinase in human PMN has recently ap-
peared (Tsung et al., 1972). Whether or not the
inhibition of phagocytosis effected by elevated
intracellular cAMP is the consequence of a protein
kinase-mediated phosphorylation of some com-
ponent essential for phagocytosis is a point of
conjecture.
The authors are deeply indebted to Dr. Robert L.
Jungas for a critical examination of this manuscript .
This work was supported by U. S. Public Health
Service Grant no. Al-03260 from the National
Institute of Allergy and Infectious Disease .
Received for publication 14 May 1973, and in revised form
2 July 1973.
REFERENCES
BOURNE, H. R., R. I. LEHRER, M. J . CLINE, and K. L.
MELMON. 1971 . Cyclic 3',5'-adenosine monophos-
phate in the human leukocyte : Synthesis, degra-
dation, and effects on neutrophil candidacidal
activity. J. Clin. Invest. 50:920.
BOURNE, H. R., R. I . LEHRER, L. M. LICHTENSTEIN,
G. WEISSMANN, and R. ZURIER. 1973. Effects ofcholera enterotoxin on adenosine 3',5'-mono-
phosphate and neutrophil function . J. Clin. Invest.
52:698.
BOURNE, H. R., and K. L. MELMON. 1971 . Adenyl
cyclase in human leukocytes : Evidence for activa-
tion by separate beta adrenergic and prostaglandin
receptors. J. Pharmacol. Exp. They. 178:1.
BOWERS, C. Y., G. A. ROBISON, K. L. LEE, V. F. DE
BALBIAN, and A. V. SCHALLY. 1968. Studies on the
Mechanism of TSH Release. American Thyroid
Association, Inc., Chicago, Illinois . 55.
BUTCHER, R. W., and C. E. BAIRD. 1968. Effects of
prostaglandins on adenosine 3',5'-monophosphate
levels in fat and other tissues. J. Biol. Chem. 243:
1773.
CAGAN, R. H., and M. L. KARNOVSKY. 1964. En-
zymatic basis of the respiratory stimulation during
phagocytosis. Nature (Lond.) . 204:255.
CARE, A. D., R. F. L. BATES, and H. J. GITELMAN.
1969. The role of glucagon in the release of thyro-
calcitonin, J. Endocrinol. 43:lv.
COHN, Z. A., and S. I. MORSE. 1960. Functional and
metabolic properties of polymorphonuclear leuko-
cytes. II. The influence of a lipopolysaccharide
endotoxin. J. Exp. Med. 111:689.
ENSOR, J. M., and D. S. MUNRO. 1969. A comparison
of the in vitro actions of thyroid stimulating hor-
mone and 3',5'-adenosine monophosphate on the
mouse thyroid gland. J. Endocrinol. 43 :477.
FLEISCHER, N. R., A. DONALD, and R. W. BUTCHER.
1969. Involvement of adenosine 3',5'-monophos-
phate in release of ACTH. Am. J. Physiol. 217:1287.
GAGLIARDINO, J. J., and J. M. MARTIN. 1968.
Stimulation of growth hormone secretion in mon-
keys by adrenalin, pitressin, and adenosine 3',5'-
cyclic monophosphoric acid. Acta Endocrinol. 59:390.
GRAHAM, R. C., JR., M. J. KARNOVSKY, A. W.
SHAFER, E. A. GLASS, and M. L. KARNOVSKY. 1967.
Metabolic and morphological observations on the
effect of surface-active agents on leukocytes . J. Cell
Biol. 32 :629.
GREENGARD, P., S. A. RUDOLPH, and J. M. STURTE-
VANT. 1969. Enthalpy of hydrolysis of the 3' bond
of adenosine 3',5'-monophosphate and guanosine
3',5'-monophosphate. J. Biol. Chem. 244:4798.
KOWALSKI, K., D. BABIARZ, and G. BURKE. 1972.
Phagocytosis of latex beads by isolated thyroid
islets : Effects of thyrotropin, prostaglandin EI and
dibutyryl cyclic AMP. J. Lab. Clin. Med. 79:258.
LICHTENSTEIN, L. M., and S. MARGOLIS. 1968.
Histamine release in vitro : Inhibition by catechola-
mines and methylxanthines. Science (Wash. D. C.).
161 :902.
LOWREY, 0. H., N. J. ROSEBROUGH, A. L. FARR, and
R. J. RANDALL. 1951 . Protein measurement with
the folin phenol reagent. J. Biol. Chem. 193 :265.
MANGANIELLO, V., W. H. EVANS, T. P. STOSSEL, R. J.
MASON, and M. VAUGHAN. 1971. The effect of
polystyrene beads on cyclic 3',5'-adenosine mono-
phosphate concentrations in leukocytes . J. Clin.
Invest. 50 :2741 .
MAY, C. D., B. B. LEVINE, and G. WEISSMANN . 1970.
Effects of compounds which inhibit antigenic re-
lease of histamine and phagocytic release of lyso-
somal enzymes on glucose utilization by leukocytes
in humans. Proc. Soc. Exp. Biol. Med. 133:758.
MICHELL, R. H., S . J. PANCAKE, J . NOSEWORTHY, and
M. L. KARNOVSKY. 1969. Measurement of rates of
phagocytosis. The use of cellular monolayers. J.
Cell Biol. 40:216.
OREN, R., A. E. FARNHAM, K. SAITO, E . MILOFSKY,
and M. L. KARNOVSKY. 1963. Metabolic patterns
in three types of phagocytizing cells. J. Cell Biol.
17 :487.
PARK, B. H., R. A. GOOD, N. P. BECK, and B. B.
DAVIS. 1971. Concentration of cyclic adenosine
3',5'-monophosphate in human leukocytes during
phagocytosis. Nat. New Biol. 229:27.
ROBISON, G. A., R. W. BUTCHER, and E. W. SUTHER-
LAND. 1971 . cAMP. Academic Press, Inc., New
York. 97-106.
SBARRA, A. J., and M. L. KARNOVSKY. 1959. The
biochemical basis of phagocytosis . I Metabolic
changes during the ingestion of particles by poly-
morphonuclear leukocytes. J. Biol. Chem. 234:1355.
SCOTT, R. E. 1970. Effects of prostaglandins, epineph-
rine and NaF on human leukocyte, platelet, and
liver adenyl cyclase. Blood. J. Hematol. 35:514.
SMITH, J. W., A. L. STEINER, W. M. NEWBERRY, JR.,
and C. W. Parker. 1971 a. Cyclic adenosine 3',5'-
monophosphate in human lymphocytes. Altera-
tions after phytohemagglutinin stimulation . J.
Clin. Invest. 50:432.
SMITH, J. W., A. L. STEINER, and C. W. PARKER.
1971 b. Human lymphocyte metabolism. Effects of
cyclic and noncyclic nucleotides on stimulation by
phytohemagglutinin. J. Clin. Invest. 50 :442.
STOLC, V. 1972. Regulation of iodine metabolism in
human leukocytes by adenosine 3',5'-monophos-
phate. Biochim. Biophys. Acta. 264:285.
STOSSEL, T. P., R. J . MASON, J. HARTWIG, and M.
VAUGHN . 1972. Quantitative studies of phagocyto-
sis by polymorphonuclear leukocytes : Use of
emulsions to measure the initial rate of phagocyto-
sis. J. Clin. Invest. 51 :615.
STOSSEL, T. P., F. MURAD, R. J . MASON, and M.
VAUGHAN. 1970. Regulation of glycogen metabo-
lism in polymorphonuclear leukocytes . J. Biol.
Chem. 245:6228.
SUSSMAN, K. E., and G. D. VAUGHN. 1967. Insulin
release after ACTH, glucagon and adenosine
3',5'-phosphate (cyclic AMP) in the perfused iso-
lated rat pancreas . Diabetes. 16:449.
SZABO, M., and G. BURKE. 1972. Uptake and metabo-
JOYCE P. COX AND MANFRED L . KARNOVSKY cAMP, Prostaglandins, and Phagocytosis
	
489lism of 3',5'-cyclic adenosine monophosphate and
N°, 021-dibutyryl 3',5'-cyclic adenosine in isolated
bovine thyroid cells. Biochim. Biophys. Ada. 264:289.
TsuNG, P., N. HERMINA, and G. WEISSMANN . 1972 .
Inosine 3',5'-monophosphate and adenosine 3',5'-
monophosphate-dependent protein kinase from
human PMN leucocytes. Biochem. Biophys. Res.
Commun. 49:1657.
WALSH, D. A., E. G. KREBS, and E. M. REIMANN.
1970. The receptor protein for cyclic AMP in the
control of glycogenolysis. Advances in Biochemical
Psychopharmacology. Vol. 3. Role of Cyclic AMP
in Cell Function. P. Greengard and E. Costra,
editors. Raven Press, New York . 265-285.
490
	
THE JOURNAL OF CELL BIOLOGY . VOLUME 59, 1973
WEISSMANN, G., P. DUKOR, and G. SESSA. 1971 .
Studies on lysosomes: Mechanisms of enzyme re-
lease from endocytic cells and a model for latency
in vitro. In Immunopathology of Inflammation.
B. K. Forscher, and J . C. Houck, editors. Excerpta
Medica Foundation, Publishers, Amsterdam. 107.
WEISSMANN, G., R. B. ZURIER, and S. HOFFSTEIN.
1972. Leukocytic proteases and the immunologic
release of lysosomal enzymes. Am. J. Pathol. 68:539.
W000IN, A. M. 1972 . Adenylate cyclase and the
function of cyclic adenosine 3',5'-monophosphate
in the leucocidin-treated leukocyte. Biochim.
Biophys. Ada. 286:406.